Investment in Related Party (Details) - USD ($) $ / shares in Units, $ in Thousands		12 Months Ended
Jul. 14, 2024	Dec. 31, 2024
Investment in Related Party [Line Items]
Acquired shares		2,100,000
Acquired Additional Issued Shares	500
Ownership percentage		8.86%
Accustem Sciences Inc [Member]
Investment in Related Party [Line Items]
Share price		$ 0.45
Finance expense		$ 238
OKYO Pharma Ltd [Member]
Investment in Related Party [Line Items]
Share price		$ 1.15
Finance expense		$ 727

The amount that comprises the change in the carrying amount of the group of insurance contracts arising from: (a) the effect of the time value of money and changes in the time value of money; and (b) the effect of financial risk and changes in financial risk; but (c) excluding any such changes for groups of insurance contracts with direct participation features that would adjust the contractual service margin but do not do so when applying paragraphs 45(b)(ii), 45(b)(iii), 45(c)(ii) or 45(c)(iii) of IFRS 17.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 17
-IssueDate 2024-01-01
-Paragraph 110
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_110&doctype=Standard
-URIDate 2024-03-27

Name:	ifrs-full_InsuranceFinanceIncomeExpenses
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration